First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

NCT04401020 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
47
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi